Polpharma Biologics’ Vedolizumab Biosimilar PB016 Accepted for FDA and EMA Review, Advancing Access to Biologic Therapy for Inflammatory Bowel Disease Polpharma Biologics International AG has announced that its proposed vedolizumab…
PHC Corporation of North America Launches Cell-IQ® CO₂ Incubator Series with Advanced Humidity Control and Contamination Prevention PHC Corporation of North America (PHCNA), a leading provider of PHCbi laboratory equipment…
Contineum Therapeutics Reports Second Quarter 2026 Financial Results and Reaffirms Clinical Development Milestones Across Inflammatory and Fibrotic Disease Pipeline Contineum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing differentiated…
CareDx Reports Strong Second Quarter 2026 Results with 52% Revenue Growth and Raises Full-Year Financial Outlook CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnostics company focused on transplant medicine,…
Meitheal Pharmaceuticals Secures FDA Approval for Garzulys™ Biosimilar Insulin to Expand Diabetes Care in the U.S. Meitheal Pharmaceuticals, Inc., a Chicago-based biopharmaceutical company focused on the development and commercialization of…
PVP Labs to Present Taphalgin® Research at 2026 Military Health System Research Symposium, Highlighting a Novel Battlefield Pain Management Approach PVP Labs, a clinical-stage biotechnology company focused on developing innovative…
Feinstein Institutes Researchers Discover the Brain’s Respiratory Alarm Mechanism Researchers at Northwell Health’s Feinstein Institutes for Medical Research have uncovered a previously unknown brain circuit that continuously monitors every breath…
miRecule and Rio Biofarma Brasil Partner to Advance Next-Generation RNA Delivery Technologies miRecule, Inc., a biotechnology company focused on developing next-generation RNA therapeutics for rare genetic diseases, has entered into…
Cofactor Genomics Appoints Renowned Oncologist Dr. Howard H. Bailey as Chief Medical Officer to Advance Precision Immunotherapy Diagnostics Cofactor Genomics, a commercial-stage diagnostics company focused on advancing precision oncology through…
Johnson & Johnson Partners with Sail Biomedicines to Advance In Vivo CAR-T Therapies for Immune-Mediated Diseases Johnson & Johnson has announced a broad strategic collaboration with Sail Biomedicines, a biotechnology…
Latigo Biotherapeutics Publishes Positive Phase 2 LTG-001 Acute Pain Trial Results in The New England Journal of Medicine Latigo Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing innovative non-opioid…
Pfizer and BioNTech Receive European Commission Approval for 2026–2027 XFG-Adapted COVID-19 Vaccine Across Europe Pfizer Inc. and BioNTech SE have announced that the European Commission (EC) has granted marketing authorization…